The acute toxicity results of the GETUG-AFU 22 study: A multicenter randomized phase II trial comparing the efficacy of a short hormone therapy in combination with radiotherapy to radiotherapy alone as a salvage treatment for patients with detectable PSA after radical prostatectomy.

Authors

null

Stephane Gilles Guerif

Centre Hospitalier Universitaire de Poitiers, Poitiers, France

Stephane Gilles Guerif , Igor Latorzeff , Lise Roca , Djelila Allouache , Stephane Supiot , Edouard Lagneau , Pierre Richaud , Deniaud-Alexandre Elisabeth , Philippe Ronchin , Benyoucef Ahmed , Lysian Cartier , Hadji Hamidou , Ali Hasbini , Gilles Crehange , Pascal Pommier , Guy De Laroche , Muriel Habibian , Emmanuel Gross , Philippe Fourneret , Laurent Salomon

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer,Prostate Cancer

Sub Track

Prostate Cancer - Localized Disease

Clinical Trial Registration Number

NCT01994239

Citation

J Clin Oncol 35, 2017 (suppl 6S; abstract 16)

DOI

10.1200/JCO.2017.35.6_suppl.16

Abstract #

16

Poster Bd #

B3

Abstract Disclosures

Similar Posters

First Author: Stephane Supiot

First Author: John Nikitas

First Author: Jose Mauricio Mota